• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
ELNagar, H. (2021). THE ROLE OF SERUM WISTERIA FLORIBUNDA AGGLUTINATION POSITIVE MAC-2 BINDING PROTEIN IN PREDICTION OF ESOPHAGEAL VARICES IN HEPATITIS C VIRUS-RELATED CIRRHOTIC PATIENTS. ALEXMED ePosters, 3(2), 18-19. doi: 10.21608/alexpo.2021.66010.1130
Haidy Ali ELNagar. "THE ROLE OF SERUM WISTERIA FLORIBUNDA AGGLUTINATION POSITIVE MAC-2 BINDING PROTEIN IN PREDICTION OF ESOPHAGEAL VARICES IN HEPATITIS C VIRUS-RELATED CIRRHOTIC PATIENTS". ALEXMED ePosters, 3, 2, 2021, 18-19. doi: 10.21608/alexpo.2021.66010.1130
ELNagar, H. (2021). 'THE ROLE OF SERUM WISTERIA FLORIBUNDA AGGLUTINATION POSITIVE MAC-2 BINDING PROTEIN IN PREDICTION OF ESOPHAGEAL VARICES IN HEPATITIS C VIRUS-RELATED CIRRHOTIC PATIENTS', ALEXMED ePosters, 3(2), pp. 18-19. doi: 10.21608/alexpo.2021.66010.1130
ELNagar, H. THE ROLE OF SERUM WISTERIA FLORIBUNDA AGGLUTINATION POSITIVE MAC-2 BINDING PROTEIN IN PREDICTION OF ESOPHAGEAL VARICES IN HEPATITIS C VIRUS-RELATED CIRRHOTIC PATIENTS. ALEXMED ePosters, 2021; 3(2): 18-19. doi: 10.21608/alexpo.2021.66010.1130

THE ROLE OF SERUM WISTERIA FLORIBUNDA AGGLUTINATION POSITIVE MAC-2 BINDING PROTEIN IN PREDICTION OF ESOPHAGEAL VARICES IN HEPATITIS C VIRUS-RELATED CIRRHOTIC PATIENTS

Article 87, Volume 3, Issue 2, June 2021, Page 18-19  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.66010.1130
View on SCiNiTO View on SCiNiTO
Author
Haidy Ali ELNagar email
Department of Tropical Medicine, Faculty of Medicine, Alexandria University
Abstract
HCV infection is one of the main causes of chronic liver disease worldwide.
Liver cirrhosis is the final stage of chronic liver injury with a high mortality.
The transition from compensated forms to decompensated cirrhosis occurs at
a rate of 5-7% per year. Once patients have developed the first episode of decompensation, complications tend to accumulate and life expectancy is dramatically decreased. Portal Hypertension is the initial and main consequence of cirrhosis and is responsible for the majority of its complications such as ascites, hepatic encephalopathy and gastroesophageal varices. Variceal haemorrhage is considered the most lethal complications of portal hypertension with a six-week mortality after an episode of bleeding ranges between 15% and 25%. So early detection and management of esophageal varices is very crucial in cirrhotic patients.
Serum WFA- M2BP, is a cell adhesive glycoprotein of the extracellular matrix secreted as a ligand of galectin 3.It is secreted from many cell types, particularly hepatocytes. It has been shown to increase with the progression of liver fibrosis.
Keywords
Liver cirrhosis; gastroesophageal varices; Serum WFA- M2BP
Supplementary Files
download 0018 Presentation10 (4).pdf
Statistics
Article View: 171
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.